Form 4: Arthur J. Gallagher & Co. Executive Acquires Stock Options
SEC Filing Form 4
Walter D. Bay, General Counsel of Arthur J. Gallagher & Co., reports acquisition of stock options.
Summary
- Walter D. Bay, General Counsel of Arthur J. Gallagher & Co., filed a Form 4 on March 5, 2025, reporting a transaction.
- The transaction involved the acquisition of 11,350 non-qualified stock options on March 1, 2025.
- The exercise price of the stock options is $337.74, based on the closing price of Gallagher common stock on February 28, 2025.
- The stock options become exercisable in three equal installments on the 3rd, 4th, and 5th anniversaries of the grant date, and expire on March 1, 2032.
Sentiment
Score: 6
Explanation: The document is neutral, simply reporting a routine stock option grant. It doesn't contain overtly positive or negative information.
Positives
- The acquisition of stock options by a high-ranking executive could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a grant of stock options to a key executive, which is a common practice in publicly traded companies to incentivize performance and align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in the insurance brokerage industry, aligning executive incentives with shareholder value.
- Companies like Marsh & McLennan (MMC) and Aon (AON) also utilize stock options as part of their executive compensation packages.
- The vesting schedule of one-third each year for three years is a typical vesting structure.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of the shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Closing price of Gallagher common stock used to determine the exercise price of the options. |
| 03/01/2025 | Date of the stock option grant. |
| 03/05/2025 | Date the Form 4 was filed. |
| 03/01/2028 | First vesting date for one-third of the stock options. |
| 03/01/2029 | Second vesting date for one-third of the stock options. |
| 03/01/2030 | Third vesting date for one-third of the stock options. |
| 03/01/2032 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.